Holiferm
PrivateLast Round
Series B
Dec 6, 2023
Total Funding Raised
$34.27M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Holiferm is a biotechnology company that develops processes for and manufactures innovative, green and sustainable biosurfactants.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Holiferm Comparables
Compare Holiferm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biotensidon GmbH | 87% | |
| AGAE Technologies | 84% | |
| AmphiStar | 84% |
Holiferm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 6, 2023 | ||||
| VC Round | Jul 31, 2023 | ||||
| Series A | Nov 12, 2021 | ||||
| Grant | Nov 9, 2020 | ||||
| Seed | May 1, 2019 |
Key People
Founding team and executive leadership
Holiferm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Liverpool City Region Local Enterprise Partnership | Grant |
| ICOS Capital | Series A, Seed |
| Rhapsody Venture Partners | Series B, Series A |
| Clean Growth Investment Management | Series A, Series B |
| Greater Manchester Combined Authority | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 70% MoM.
- Jun 18, 2026
Monthly visitors increased 112% MoM.
Recent news
Latest coverage and updates
- attends_eventOct 7, 2026
Holiferm attends SEPAWA congress 2026
- is_developingSep 14, 2026
Holiferm is developing novel performance biochemicals on Sep 8th '26.
- acquiresSep 8, 2026
On Sep 8th '26, Holiferm acquires Organica UK Ltd in the United Kingdom, combining biosurfactant innovation and manufacturing with formulation and finished-product capabilities to commercialise sustainable cleaning products.
Holiferm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Holiferm's valuation, stock price, and market status.
Is Holiferm a public or private company?
Holiferm is a private company.
What is the current stock price of Holiferm?
Holiferm is a private company, so its shares have no public market price. Caplight tracks Holiferm's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Holiferm worth (valuation)?
Valuation information for Holiferm is not publicly available.
Can I buy Holiferm stock?
Holiferm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Holiferm's last funding round?
Holiferm's most recent funding round was Series B on December 6, 2023.
Who are the main investors in Holiferm?
Key investors in Holiferm include ICOS Capital, Rhapsody Venture Partners, Clean Growth Investment Management.
Will Holiferm IPO soon?
No public IPO plans have been announced for Holiferm.
How can I track Holiferm secondary market activity?
Caplight tracks bids, offers, and trades in Holiferm's shares on secondary markets.